ArticleJournal of clinical medicine2025

Comparison of Second-Line Chemotherapies for First-Relapsed High-Grade Serous Ovarian Cancer: A Retrospective Study.

Jeongyun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.